Would primary sclerosing cholangitis, alcoholic liver disease, and hepatocellular carcinoma require protein restrictions?

• A. Yes
• B. No
• C. Only PSC
• D. Only alcoholic liver disease

Answer: (B)

In liver disease, protein needs are not simply restricted across the board. These conditions put patients at high risk for malnutrition and muscle wasting, and protein is essential for healing and immune function. Restricting protein can worsen malnutrition and outcomes, so there isn’t a blanket requirement to limit protein for conditions like primary sclerosing cholangitis, alcoholic liver disease, or hepatocellular carcinoma.

The situation changes if hepatic encephalopathy is present. In that case, clinicians may adjust protein intake temporarily and focus on controlling ammonia with treatments like lactulose or rifaximin, but modern practice does not advocate a universal, long-term protein restriction for all patients with these liver conditions. The goal is to maintain adequate protein intake appropriate for the patient’s metabolic needs and level of catabolic stress, rather than applying a broad restriction.

So, none of these conditions require routine protein restriction; the emphasis is on preserving nutrition and only limiting protein in the specific, acute context of encephalopathy as part of a broader management plan.